[Home oxygen therapy; indications are still limited]

Area of Science:

• Pulmonary Medicine
• Respiratory Care

Background:

• Long term oxygen treatment (LTOT) is traditionally prescribed for severe hypoxemia (PaO2 < 8.0 kPa) at rest, based on older research.
• Established guidelines recommend LTOT use for at least 15 hours daily.

Purpose of the Study:

• To evaluate the current role and optimal application of LTOT in COPD management.
• To assess how LTOT integrates with emerging respiratory support modalities.

Main Methods:

• Review of existing literature on LTOT efficacy and guidelines.
• Analysis of studies investigating newer treatments like nocturnal non-invasive ventilatory support.
• Consideration of individualized patient approaches in COPD care.

Main Results:

• Severe resting hypoxemia (PaO2 < 8.0 kPa) remains a key criterion for LTOT initiation.
• Nocturnal non-invasive ventilatory support has demonstrated significant benefits in COPD management.
• LTOT is increasingly viewed as one component within a broader, multidimensional treatment strategy.

Conclusions:

• LTOT prescription criteria, while historically defined, require contextualization within modern COPD treatment paradigms.
• The integration of LTOT with other therapies, such as ventilatory support, is crucial for optimizing patient outcomes.
• A personalized, multidimensional approach is essential for effective COPD management, incorporating LTOT where appropriate.